Trial intelligence / Profile preview

Gabapentin and Ramosetron for PONV in Laparoscopic Gynecological Surgery

NCT02617121Unknown

Sponsor
Hallym University Medical Center
Start
Nov 2015
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

Trial of gabapentin and ramosetron in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Hallym University Medical Center. Primary endpoint: Incidence of postoperative nausea and vomiting. Status: unknown.

02

Drugs

gabapentinramosetron
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT02617121.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02617121.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call